• Magazine
  • ENEWS
  • SUBSCRIBE
  • WEBINARS
  • PODCASTS
  • EBOOKS
    1. Home

    GAO study criticizes FDA’s record on postmarket decisionmaking

    April 29, 2006
    On a more serious note, in case you missed this, the Government Accounting Office just released a report this week analyzing FDA's  effectiveness in postmarket drug safety decisionmaking, and factors that may have influenced it.
    On a more serious note, in case you missed this, the Government Accounting Office just released a report this week analyzing FDA's  effectiveness in postmarket drug safety decisionmaking, and factors that may have influenced it.

    About the Author

    pharmamanufacturing | pharmamanufacturing